Pacific Biosciences plunges 15.44%: losses expected and revenue declining
FROM THE WIRE · FINANCE.YAHOO.COM
Pacific Biosciences of California (PACB) closed the most recent trading day at $2.30, moving -15.44% from the previous trading session. This move lagged the S&P 500's daily loss of 0.47%. Meanwhile, the Dow gained 0.1%, and the Nasdaq, a tech-heavy index, lost 1.25%. The stock…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishPACB down 15.44%, far worse than market, despite 110.85% rally in prior month, with losses and declining revenue expected.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01PACB closes -15.44% while S&P 500 loses 0.47%, Nasdaq down 1.25%.
- 02Expected EPS of -$0.13, down 8.33% versus same quarter prior year.
- 03Forecast revenue of $37.86 million, down 1.51% year-over-year.
- 04Stock rose 110.85% in prior month but today records sharp correction.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Pacific Biosciences of California, Inc.2.30 USDMarket closedtoday -15.44%Negative S&P 5007,765.70Market closedtoday -0.46%Negative Dow Jones Industrial Average51,231.64Market closedtoday +0.10%Positive NASDAQ Composite27,193.34Market closedtoday -1.25%Negative
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets